The forecast for the number of clinically diagnosed relapse pulmonary tuberculosis cases in Japan shows a consistent decline from 54 cases in 2024 to 27 cases by 2028. This steady decrease reflects a significant year-on-year reduction, evident with an annual decline of approximately 14% from 2024 to 2028. The compound annual growth rate (CAGR) indicates an average yearly decrease in cases, highlighting successful public health interventions and advancements in tuberculosis management.
Future trends to watch for include the impact of further advancements in medical treatments, the effectiveness of public health campaigns, and potential changes in the demographic and health behaviors of the population. Continuous monitoring of these factors is crucial to sustaining the trend and achieving even lower incidence rates.
